BASF Shares Approach Record Territory Amid Strategic Shifts

BASF nears €7.7B coatings sale, enacts major price increases, and sees stock hit 52-week high as analysts debate its outlook ahead of key Q1 report.

The German chemical giant BASF is currently executing multiple strategic maneuvers simultaneously. From significant price adjustments to a major divestiture nearing completion, alongside equity trading at yearly peaks, the company is sending an unusually concentrated stream of signals to the market.

Divestiture Nears Completion

A landmark transaction is progressing toward its final stages. The sale of the BASF Coatings division to the financial investor Carlyle is now on a clear timetable, with a total deal value established at €7.7 billion. Upon closing, BASF is set to receive a pre-tax cash inflow of approximately €5.8 billion and will retain a 40 percent stake in the now-separated entity. Jens Luehring has been appointed as the future CEO of the standalone coatings business. The parties anticipate finalizing the transaction in the second quarter of 2026.

Widespread Price Adjustments Enacted

Concurrently, BASF has initiated substantial price increases across several product lines, citing heightened operational costs. In Europe, the company's standard amine portfolio—including ethanolamines, ethylenamines, and methylamines—faces immediate price hikes of up to 30 percent. The firm attributes this move to increased raw material, energy, and logistics costs stemming from the ongoing conflict in the Middle East.

Parallel actions are underway in the home care and cleaning products segments within Europe. Furthermore, equivalent pricing levels for these products are scheduled to take effect across North and South America starting April 1, 2026. Industry observers note potential ripple effects; elevated amine prices could subsequently raise production costs for herbicides, thereby increasing operational expenses for the agricultural sector.

Analyst Views Diverge as Stock Tests Highs

Market experts present a divided outlook on the company's trajectory. J.P. Morgan analyst Chetan Udeshi maintains an Underweight rating with a price target of €36, arguing that the share price has become disconnected from fundamentals. He points out that the EBITDA forecast for 2026 does not substantiate expectations for an imminent earnings turnaround.

In contrast, Deutsche Bank analyst Virginie Boucher-Ferte has upgraded her rating from Hold to Buy, raising her price target to €55. This reassessment comes as BASF's shares closed at a new 52-week high of €52.64, representing a gain of roughly 32 percent above the low point reached in April of the previous year.

Upcoming Quarterly Report to Serve as Litmus Test

The market will receive its first concrete evidence of whether the recent price initiatives and cost-saving measures are translating to the bottom line on April 30, 2026. On this date, BASF is scheduled to present its first-quarter results concurrently with its Annual General Meeting. This report will serve as a critical, early indicator of the progress within the company's broader restructuring program.